# OnCo record quincy-chu (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/quincy-chu/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "quincy-chu" ;
  schema:name "Quincy Chu"@en ;
  schema:description "Edmonton oncologist who was lead author of KEYNOTE-483 (CCTG IND.227), the trial that showed adding pembrolizumab to chemotherapy lengthens survival in pleural mesothelioma."@en ;
  schema:url <https://onco.cc/people/quincy-chu/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "mesothelioma", "immunotherapy", "trialist" ;
  schema:jobTitle "Medical oncologist, Cross Cancer Institute and University of Alberta, Edmonton" ;
  onco:cancers <https://onco.cc/cancers/pleural-mesothelioma/> ;
  onco:institutions <https://onco.cc/institutions/cancer-care-alberta/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-keynote-483-lancet-2023/> ;
  schema:affiliation <https://onco.cc/institutions/cancer-care-alberta/> .